Skip to main content

Table 3 Predictors of CRNA in Canada

From: Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact

Predictor No. of articles reporting significance Citations
Higher out-of-pocket costsa 13 [2, 3, 37, 39,40,41, 47, 50,51,52,53, 55, 56]
Lower income or low financial flexibility 9 [3, 38,39,40, 43, 46, 48, 54, 55]
Lack of drug insurance 7 [40, 41, 43, 46, 47, 54, 55]
Younger age 6 [38,39,40, 43, 46, 47]
Poor self-reported health status 5 [39, 40, 43, 46, 47]
Province of residence (e.g., Ontario instead of Quebec, or British Columbia instead of Ontario or Quebec) 4 [38, 43, 46, 47]
Several chronic health conditions 2 [38, 46]
High cost of drugs 2 [35, 54]
Low/medium drug importance from individual’s perspective 2 [54, 55]
Not feeling involved in treatment decisions 2 [39, 55]
First Nations status 1 [39]
  1. aIncludes studies comparing the rates of CRNA pre- and post-copayment policy